Brian Mark Gilfix
Impact in
- Rheumatology top 2%
- Folate and B Vitamins Research
- Clinical Biochemistry top 5%
- Metabolism and Genetic Disorders
Papers in
- Rheumatology 20
- Folate and B Vitamins Research 18
-
- Metabolism and Genetic Disorders 6
- Co-authors
- David S. Rosenblatt (14 shared papers)Judes Poirier (2 shared papers)Josephine N. Nalbantoglu (2 shared papers)Richard L. Eckert (1 shared paper)David W. Blank (4 shared papers)Sheldon A. Magder (1 shared paper)Martin Rhys Farlow (1 shared paper)Rémi Quirion (1 shared paper)
- Journals
- Molecular Genetics and Metabolism (7 papers)Clinical Biochemistry (3 papers)Clinical Toxicology (3 papers)The American Journal of Cardiology (2 papers)Human Mutation (2 papers)
- Partner nations
- CanadaUnited StatesFrance
In The Last Decade
Brian Mark Gilfix
63 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 104
- Rheumatology 430
- Clinical Biochemistry 108
- Physiology 437
- Pharmacology 163
- Nephrology 161
Countries citing papers authored by Brian Mark Gilfix
This map shows the geographic impact of Brian Mark Gilfix's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Mark Gilfix with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Mark Gilfix more than expected).
Fields of papers citing papers by Brian Mark Gilfix
This network shows the impact of papers produced by Brian Mark Gilfix. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Mark Gilfix. The network helps show where Brian Mark Gilfix may publish in the future.
Co-authors
The 25 scholars most cited alongside Brian Mark Gilfix, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 64 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 502 | |
| 2 | 1999 | 251 | |
| 3 | 1993 | 170 | |
| 4 | 1997 | 148 | |
| 5 | 1985 | 124 | |
| 6 | 1994 | 124 | |
| 7 | 1996 | 117 | |
| 8 | 1993 | 61 | |
| 9 | 1995 | 58 | |
| 10 | 1984 | 49 | |
| 11 | 2020 | 49 | |
| 12 | 1997 | 41 | |
| 13 | 1980 | 38 | |
| 14 | 2009 | 37 | |
| 15 | 2015 | 35 | |
| 16 | 2001 | 34 | |
| 17 | 1995 | 33 | |
| 18 | 2002 | 32 | |
| 19 | 2012 | 32 | |
| 20 | 1994 | 31 |
About Brian Mark Gilfix
Brian Mark Gilfix is a scholar working on Rheumatology, Clinical Biochemistry, Physiology, Molecular Biology and Psychiatry and Mental health, having authored 64 papers that have together received 2.4k indexed citations. Recurring topics across this work include Folate and B Vitamins Research (18 papers), Glycosylation and Glycoproteins Research (8 papers), Metabolism and Genetic Disorders (6 papers), Dementia and Cognitive Impairment Research (5 papers), Clinical Laboratory Practices and Quality Control (3 papers), Alzheimer's disease research and treatments (3 papers), Lysosomal Storage Disorders Research (3 papers) and Genomics and Rare Diseases (3 papers). The work is most often cited by research in Rheumatology (430 citations), Clinical Biochemistry (108 citations), Physiology (437 citations), Pharmacology (163 citations) and Nephrology (161 citations). Brian Mark Gilfix has collaborated with scholars based in Canada, United States and France. Frequent co-authors include David S. Rosenblatt, Judes Poirier, Josephine N. Nalbantoglu, Richard L. Eckert, David W. Blank, Sheldon A. Magder, Martin Rhys Farlow, Rémi Quirion, Siu Lui Hui and Debomoy K. Lahiri. Their work appears in journals such as Molecular Genetics and Metabolism, Clinical Biochemistry, Clinical Toxicology, The American Journal of Cardiology and Human Mutation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.